Defibrillators Market Size to cross USD 26.2 billion by 2035

The global defibrillators market was valued at USD 14.9 billion in 2025 and is expected to grow from USD 16.2 billion in 2026 to USD 26.2 billion in 2035, growing at a CAGR of 5.5% during the forecast period, according to the latest report published by Global Market Insights Inc.

Rising prevalence of cardiovascular diseases and sudden cardiac arrest.

The rising prevalence of cardiovascular diseases and sudden cardiac arrest is a major factor driving demand for defibrillator devices globally. The increasing burden of conditions such as coronary artery disease, heart failure, and arrhythmias has significantly elevated the risk of life-threatening cardiac events across both developed and emerging economies.

Technological advancements in implantable and automated defibrillators.

Technological advancements in implantable and automated defibrillators are also significantly enhancing market growth by improving device efficiency, accuracy, and ease of use. Modern defibrillators are increasingly equipped with advanced sensing algorithms, real-time cardiac rhythm analysis, and improved shock delivery precision, enabling faster and more reliable treatment responses.

High cost of defibrillator devices and maintenance.

The high cost of defibrillator devices and maintenance remains a significant barrier to widespread adoption across both developed and emerging healthcare markets. Advanced defibrillators, particularly implantable cardioverter defibrillators (ICDs) and feature-rich automated external defibrillators (AEDs), involve substantial upfront procurement costs due to sophisticated electronics, precision engineering, and integrated monitoring technologies.

Browse key industry insights spread across 130 pages with 161 market data tables and figures from the report, Defibrillators Market, “By Product (Implantable Cardioverter Defibrillator, External Cardioverter Defibrillator), and By End Use (Hospitals, Ambulatory Surgical Centers, Other End Users)” in detail, along with the table of

contents:https://www.gminsights.com/industry-analysis/defibrillators-market

Implantable cardioverter defibrillator to drive market growth

The implantable cardioverter defibrillator (ICD) segment held a 71.3% share in 2025. This dominance is primarily supported by growing clinical preference for long-term management of life-threatening arrhythmias, a rising incidence of sudden cardiac arrest, and the strong reliance of physicians on implantable solutions for patients categorized as high risk.

Hospitals to gain traction

The hospitals segment held 67.8% share in 2025 and is projected to reach USD 18 billion. Hospitals function as primary critical care centers equipped with advanced defibrillation systems, including both ICDs and AEDs, to manage severe and life-threatening cardiac events. Their strong infrastructure, combined with the availability of trained healthcare professionals capable of operating complex emergency equipment, reinforces their dominance as the leading end-use setting in the defibrillators market.

North America to Emerge as a Propelling Region

North America defibrillators market held a 37.3% share in 2025. The region experiences a high burden of cardiovascular diseases and sudden cardiac arrest cases, driven by widespread lifestyle-related risk factors such as obesity, hypertension, diabetes, and sedentary behavior. A significant proportion of cardiac emergencies also occur outside hospital environments, which increases reliance on both automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs).

Abbott, Medtronic, Boston Scientific, Philips, Stryker, BIOTRONIK, Nihon Kohden, Mindray, SCHILLER, MicroPort, BPL Medical Technologies, CU Medical, Asahi Kasei, Amiitalia, and MEDITECH operate as key players in the global defibrillators market.

Companies in the AI-enabled defibrillators market are increasingly focusing on integrating predictive analytics, real-time ECG interpretation, and machine learning algorithms to improve early detection of life-threatening arrhythmias. Strategic investments in smart wearable integration and cloud-connected monitoring platforms are enabling continuous patient surveillance and faster emergency response coordination. Manufacturers are also prioritizing device miniaturization, improved battery efficiency, and enhanced shock delivery accuracy to improve clinical outcomes and patient comfort.

In January 2026, Medtronic launched OmniaSecure defibrillation lead in the U.S. and reported that the first procedures were performed at hospitals across the country.